Aethlon Medical ROE 2010-2024 | AEMD

Current and historical return on equity (ROE) values for Aethlon Medical (AEMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Aethlon Medical ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-09-30 $-0.01B $0.01B -151.72%
2024-06-30 $-0.01B $0.01B -133.33%
2024-03-31 $-0.01B $0.01B -118.92%
2023-12-31 $-0.01B $0.01B -95.65%
2023-09-30 $-0.01B $0.01B -80.00%
2023-06-30 $-0.01B $0.01B -73.85%
2023-03-31 $-0.01B $0.02B -71.64%
2022-12-31 $-0.01B $0.02B -81.16%
2022-09-30 $-0.01B $0.02B -76.71%
2022-06-30 $-0.01B $0.02B -63.16%
2022-03-31 $-0.01B $0.02B -51.16%
2021-12-31 $-0.01B $0.02B -46.15%
2021-09-30 $-0.01B $0.02B -47.06%
2021-06-30 $-0.01B $0.03B -54.24%
2021-03-31 $-0.01B $0.01B -57.14%
2020-12-31 $-0.01B $0.01B -57.14%
2020-09-30 $-0.01B $0.01B -57.14%
2020-06-30 $-0.01B $0.02B -85.71%
2020-03-31 $-0.01B $0.01B -200.00%
2019-12-31 $-0.01B $0.00B -400.00%
2019-09-30 $-0.01B $0.00B -533.33%
2019-06-30 $-0.01B $0.00B -280.00%
2019-03-31 $-0.01B $0.00B -171.43%
2018-12-31 $-0.01B $0.00B -111.11%
2018-09-30 $-0.00B $0.00B -80.00%
2018-06-30 $-0.00B $0.01B -100.00%
2018-03-31 $-0.01B $0.01B -200.00%
2017-12-31 $-0.01B $0.01B -480.00%
2017-09-30 $-0.01B $0.00B inf%
2017-06-30 $-0.01B $-0.00B inf%
2017-03-31 $-0.01B $0.00B -2800.00%
2016-12-31 $-0.01B $0.00B -1200.00%
2016-09-30 $-0.01B $0.00B -480.00%
2016-06-30 $-0.01B $0.00B -222.22%
2016-03-31 $-0.00B $0.00B -114.29%
2015-12-31 $-0.00B $0.00B -123.08%
2015-09-30 $-0.01B $0.00B -181.82%
2015-06-30 $-0.01B $0.01B -500.00%
2015-03-31 $-0.01B $0.00B 640.00%
2014-12-31 $-0.01B $0.00B 266.67%
2014-09-30 $-0.01B $-0.00B 169.70%
2014-06-30 $-0.02B $-0.00B 152.38%
2014-03-31 $-0.01B $-0.02B 102.13%
2013-12-31 $-0.01B $-0.01B 78.05%
2013-09-30 $-0.01B $-0.01B 64.86%
2013-06-30 $-0.00B $-0.01B 48.48%
2013-03-31 $-0.01B $-0.01B 62.50%
2012-12-31 $-0.01B $-0.01B 75.00%
2012-09-30 $-0.01B $-0.01B 90.32%
2012-06-30 $-0.01B $-0.01B 82.76%
2012-03-31 $-0.01B $-0.01B 114.29%
2011-12-31 $-0.00B $-0.01B 32.00%
2011-09-30 $-0.00B $-0.01B 42.86%
2011-06-30 $-0.01B $-0.01B 80.00%
2011-03-31 $-0.01B $-0.01B 80.00%
2010-12-31 $-0.01B $-0.01B 128.57%
2010-09-30 $-0.01B $-0.01B 139.13%
2010-06-30 $-0.01B $-0.01B 126.32%
2010-03-31 $-0.00B $-0.00B 100.00%
2009-12-31 $-0.00B $-0.00B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Health Maintenance Organizations $0.006B $0.001B
Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development of therapeutic devices that treat acute viral conditions, chronic viral diseases and pathogens targeted as potential biological warfare agents. The Hemopurifier(R) combines the established scientific principles of affinity chromatography and hemodialysis as a means to mimic the immune system's response of clearing viruses and toxins from the blood before cell and organ infection can occur. The Hemopurifier(R) cannot cure viral conditions but can prevent virus and toxins from infecting unaffected tissues and cells. The company has completed pre-clinical blood testing of the Hemopurifier(R) to treat HIV and Hepatitis-C, and have completed human safety trials on Hepatitis-C infected patients in India.
Stock Name Country Market Cap PE Ratio
UnitedHealth Group (UNH) United States $543.768B 21.87
Cigna Group (CI) United States $91.359B 11.95
Humana (HUM) United States $35.896B 16.34
Centene (CNC) United States $30.479B 8.94
Molina Healthcare (MOH) United States $16.633B 13.23
Select Medical Holdings (SEM) United States $5.136B 17.79
Joint (JYNT) United States $0.176B 106.82